4.7 Article

α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6β4 and α6β2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release

期刊

FASEB JOURNAL
卷 24, 期 12, 页码 5113-5123

出版社

FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.10-166272

关键词

nicotinic; alpha 6; Conus; hydroxyproline; hippocampus

资金

  1. Kirschstein-National Research Service Award [DA 016835]
  2. National Institutes of Health [DA017173, MH53631, GM48677]
  3. Institut Pasteur
  4. ANR
  5. European Union [HEALTH-F2-2008-202088]
  6. Centre National de la Recherche Scientifique
  7. Agence Nationale de la Recherche Neurologie
  8. European Commission

向作者/读者索取更多资源

alpha 6* (asterisk indicates the presence of additional subunits) nicotinic acetylcholine receptors (nAChRs) are broadly implicated in catecholamine-dependent disorders that involve attention, motor movement, and nicotine self-administration. Different molecular forms of alpha 6 nAChRs mediate catecholamine release, but receptor differentiation is greatly hampered by a paucity of subtype selective ligands. alpha-Conotoxins are nAChR-targeted peptides used by Conus species to incapacitate prey. We hypothesized that distinct conotoxin-binding kinetics could be exploited to develop a series of selective probes to enable study of native receptor subtypes. Proline6 of alpha-conotoxin BuIA was found to be critical for nAChR selectivity; substitution of proline6 with 4-hydroyx-proline increased the IC(50) by 2800-fold at alpha 6/alpha 3 beta 2 beta 3 but only by 6-fold at alpha 6/alpha 3 beta 4 nAChRs (to 1300 and 12 nM, respectively). We used conotoxin probes together with subunit-null mice to interrogate nAChR subtypes that modulate hippocampal norepinephrine release. Release was abolished in alpha 6-null mutant mice. alpha-Conotoxin BuIA[T5A;P6O] partially blocked norepinephrine release in wild-type controls but failed to block release in beta 4(-/-) mice. In contrast, BuIA[T5A;P6O] failed to block dopamine release in the wild-type striatum known to contain alpha 6 beta 2* nAChRs. BuIA[T5A;P6O] is a novel ligand for distinguishing between closely related alpha 6* nAChRs; alpha 6 beta 4* nAChRs modulate norepinephrine release in hippocampus but not dopamine release in striatum.-Azam, L., Maskos, U., Changeux, J.-P., Dowell, C. D., Christensen, S., De Biasi, M., McIntosh, J. M. alpha-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between alpha 6 beta 4 and alpha 6 beta 2 nAChRs and blocks nicotine-stimulated norepinephrine release. FASEB J. 24, 5113-5123 (2010). www.fasebj.org

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据